Orphan/Specialty Pipeline Candidates
Orphan and Specialty Indications
Not SpecifiedActive R&D
Key Facts
Indication
Orphan and Specialty Indications
Phase
Not Specified
Status
Active R&D
Company
About Aucta Pharmaceuticals
Aucta Pharmaceuticals is a private, US-based specialty pharma company with a dual-site R&D and manufacturing presence in New Jersey and Shanghai. Its strategy centers on using its proprietary AucPed, AucTrol, and AucMist technology platforms to create differentiated dosage forms of established drugs, aiming to improve patient adherence and outcomes. The company is backed by a consortium of global and China-based healthcare investors and is advancing a pipeline focused on CNS and orphan diseases.
View full company profile